Strides Arcolab has partnered with Gilead Sciences Inc whereby the
latter has licensed Strides to produce generic sofosbuvir and
investigational single tablet regimen of ledipasvir/sofosbuvir for
treatment of chronic Hepatitis C, for distribution to 91 developing
countries including India, Eqypt & Indonesia which are high burden
countries. Real Time News & Trading Trends Keep Liking Epic Research Private Limited
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
No comments:
Post a Comment